著者

Liangningyi Liu Lei Chen Jie Su

出版者

The Institute of Electronics, Information and Communication Engineers

雑誌

IEICE Electronics Express (ISSN:13492543)

巻号頁・発行日

vol.20, no.23, pp.20230380, 2023-12-10 (Released:2023-12-10)

参考文献数

32

---

This paper presents a lowpass filter for 5.8GHz Doppler radar with an intermediate frequency signal hold function, which significantly reduces system power by interrupt mode operation. Additionally, it proposes a novel complementary push-pull DC offset calibration method to calibrate the DC voltage of the lowpass filter with the common mode voltage. Compared to traditional methods, the proposed scheme effectively stabilize the quiescent operating point of the receiver. The experimental results show that the power consumption of the proposed filter is 0.019mW, calibrated DC voltage is 1.65V, and residual DC voltage is less than 1mV.

著者

Jie Su Hongzhou Lu

出版者

International Research and Cooperation Association for Bio & Socio-Sciences Advancement

雑誌

BioScience Trends (ISSN:18817815)

巻号頁・発行日

pp.2021.01227, (Released:2021-06-16)

参考文献数

62

被引用文献数

8

---

The coronavirus disease 2019 (COVID-19) pandemic has resulted in a substantial global public healthcare crisis, leading to the urgent need for effective therapeutic strategies. Neutralizing antibodies (nAbs) are a potential treatment for COVID-19. This article provides a brief overview of the targets and development of nAbs against COVID-19, and it examines the efficacy of nAbs as part of both outpatient and inpatient treatments based on emerging clinical trial data. Assessment of several promising candidates in clinical trials highlights the potential of nAbs to be an effective therapeutic to treat COVID-19 in outpatient settings. Nevertheless, the efficacy of nAbs treatment for hospitalized patients varies. In addition, this review identifies challenges to ending the COVID-19 pandemic, including concerns over nAbs development and clinical use. Resistant variants significantly threaten the availability of nAb-based therapeutics. This review also discusses other approaches that may improve the clinical benefit of neutralizing mAbs.